COMMUNIQUÉS West-GlobeNewswire

Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI

06/12/2018 - 15:30

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided a business update announcing the U.S. launch of FDA-approved SYMJEPI ™ (epinephrine) 0.3mg Injection is [...]

Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation

06/12/2018 - 15:00

DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has released an online [...]

Medidata Selects Client Outlook’s eUnity™ Smartviewer to Enable Zero-Footprint Image Viewing for Life Sciences Research

06/12/2018 - 15:00

WATERLOO, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Client Outlook , a leading provider of FDA Class II clinical and diagnostic image viewing solutions, announced today its partnership with Medidata to support the use [...]

Matinas BioPharma Assembles World Class Scientific Advisory Board to Guide Clinical Development Strategy of Potential Best-in-Class Prescription-Only Omega-3, MAT9001

06/12/2018 - 15:00

Christie M. Ballantyne, M.D., John J.P. Kastelein, M.D., Ph.D., FESC, and Kevin C. Maki, Ph.D. represent three of the world’s leading lipid specialists and cardiovascular health experts BEDMINSTER, N.J., Dec. 06, 2018 ( [...]

RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering

06/12/2018 - 14:44

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 06, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company

06/12/2018 - 14:36

Company Announcement Oncology Ventures CEO Peter Buhl Jensen buys shares in the Company Hoersholm, Denmark – December 6, 2018 – Oncology Venture A/S (OV:ST) announces that CEO Peter Buhl Jensen, through Buhl Krone [...]

Olainfarm holds Third Quarter 2018 Investor Conference Webinar

06/12/2018 - 14:34

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled today, on December 6, 2018 at 16:00 (EEST). To join the webinar please [...]

Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform

06/12/2018 - 14:31

DAVIS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), launches TerraConnect, a new global biological soil applied and seed treatment platform delivering growers high [...]

VPR Brands Letter to Shareholders 2018

06/12/2018 - 14:30

Fort Lauderdale, FL, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – VPR Brands, LP (OTC Pink: VPRB): December 6, 2018 Dear Valued Shareholders, As we enter the holiday season, I wanted to take this opportunity to [...]

NexTech Looks to Bring Augmented Reality to Ecommerce-- CFN Media

06/12/2018 - 14:30

SEATTLE, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

SELLAS Life Sciences Announces Additional Positive Triple Negative Breast Cancer (TNBC) Subgroup Data from Phase 2b Study of Nelipepimut-S Plus Trastuzumab at the 2018 San Antonio Breast Cancer Symposium

06/12/2018 - 14:30

Clinically Meaningful and Statistically Significant Decrease in the Frequency of Clinically Detected Recurrences in the TNBC Cohort Treated with Nelipepimut-S plus Trastuzumab (p=0.004) Specific Benefit in Four [...]

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™ (burosumab injection) for the Treatment of X–linked Hypophosphatemia (XLH) in Adults and Children

06/12/2018 - 14:30

First Approved Treatment for XLH in Canada that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease NOVATO, Calif., TOKYO and LONDON, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc [...]

BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA® at a Major Breast Cancer Conference

06/12/2018 - 14:30

Interim data indicate an excellent safety profile for the combination regimen in advanced breast cancer patients. Initial efficacy data is expected in first quarter of 2019; Confirmed positive proof-of-concept with Bria [...]

Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations

06/12/2018 - 14:30

SALT LAKE CITY, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the [...]

First Choice Healthcare Solutions Governance Appointments

06/12/2018 - 14:30

The Independent Board of Directors Announce Additional Updates Melbourne, Fla., Dec. 06, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company"), a physician [...]

Organovo Appoints New Board Member

06/12/2018 - 14:05

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]

Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan

06/12/2018 - 14:03

Updated Phase 2 Results in Metastatic Triple-Negative Breast Cancer to be Presented at The 2018 San Antonio Breast Cancer Symposium (SABCS) Continue to Show Meaningful Clinical Benefit Consistent with Prior Results [...]

Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations

06/12/2018 - 14:01

PLANO, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that the Company’s Algovita ® Spinal Cord Stimulation (SCS) system has been [...]

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome

06/12/2018 - 14:01

-- Single pivotal Phase 3 trial design, using once-daily dosing, may be sufficient for approval of OV101 in Angelman syndrome -- -- Trial initiation activities have begun for ELARA, an open-label extension study for [...]